These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

363 related articles for article (PubMed ID: 10399225)

  • 41. Improved white blood cell functions: additional effects of membrane plasmapheresis.
    Kayashima K; Smith JW; Barna R; Matsubara S; Abe Y; Ueno M; Katsume C; Valenzuela R; Clough JD; Malchesky PS; Nosé Y
    Trans Am Soc Artif Intern Organs; 1982; 28():312-7. PubMed ID: 7164254
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Double filtration plasmapheresis for the treatment of a rheumatoid arthritis patient with extremely high level of c-reactive protein.
    Matsuda Y; Tsuda H; Takasaki Y; Hashimoto H
    Ther Apher Dial; 2004 Oct; 8(5):404-8. PubMed ID: 15663536
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Potential novel biomarkers of disease activity in rheumatoid arthritis patients: CXCL13, CCL23, transforming growth factor alpha, tumor necrosis factor receptor superfamily member 9, and macrophage colony-stimulating factor.
    Rioja I; Hughes FJ; Sharp CH; Warnock LC; Montgomery DS; Akil M; Wilson AG; Binks MH; Dickson MC
    Arthritis Rheum; 2008 Aug; 58(8):2257-67. PubMed ID: 18668547
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [The use of hemosorption and plasmapheresis for treating cardiac arrhythmias (a preliminary report)].
    Nedostup AV; Panasiuk VV; Boldyrev DA; Kalugina GV; Ivanov MI; Komiagin IuV
    Ter Arkh; 1994; 66(8):35-6. PubMed ID: 7985150
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Lymphocyte blast transformation according to the clinical variant of rheumatoid arthritis].
    Popova L; Pekhlivanov D; Matev M; Apostolov P; Sheĭtanov I
    Vutr Boles; 1980; 19(2):39-43. PubMed ID: 6966867
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The effects of leflunomide on clinical parameters and serum levels of IL-6, IL-10, MMP-1 and MMP-3 in patients with resistant rheumatoid arthritis.
    Litinsky I; Paran D; Levartovsky D; Wigler I; Kaufman I; Yaron I; Yaron M; Caspi D; Elkayam O
    Cytokine; 2006 Jan; 33(2):106-10. PubMed ID: 16487722
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [A multicenter cross-sectional study on the health related quality of life of patients with rheumatoid arthritis using a revised Japanese version of the arthritis impact measurement scales version 2 (AIMS 2), focusing on the medical care costs and their associative factors].
    Hashimoto A; Sato H; Nishibayahi Y; Shiino Y; Kutsuna T; Ishihara Y; Hoshi K; Fujimori J; Tsuboi S; Kondo H; Akizuki M; Moroi Y; Yoshida S
    Ryumachi; 2002 Feb; 42(1):23-39. PubMed ID: 11925904
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Enhanced concentrations of interleukin 16 are associated with joint destruction in patients with rheumatoid arthritis.
    Lard LR; Roep BO; Toes RE; Huizinga TW
    J Rheumatol; 2004 Jan; 31(1):35-9. PubMed ID: 14705216
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Characteristics of healing of wounds after hemosorption in the complex treatment of severely burned patients].
    Povstianoĭ NE; Fedotov AF; Kozinets GP; Neulybin VI
    Vestn Khir Im I I Grek; 1990 Oct; 145(10):57-60. PubMed ID: 1964294
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Hemosorption in the treatment of rheumatoid arthritis].
    Piaĭ LT; Imelik KhO; Piaĭ TL; Vikhliaeva SV
    Ter Arkh; 1983; 55(9):99-101. PubMed ID: 6635987
    [No Abstract]   [Full Text] [Related]  

  • 51. [Plasmapheresis by adsorption. b. Immunoadsorption].
    Yamazaki Z; Fuzimori Y; Takahama T; Yoshizawa H; Takahashi K; Ogino T; Yamawaki N; Inagaki K; Tsuda N
    Nihon Rinsho; 1984 Aug; 42(8):1784-95. PubMed ID: 6392604
    [No Abstract]   [Full Text] [Related]  

  • 52. The role of anti-mutated citrullinated vimentin antibodies in the diagnosis of early rheumatoid arthritis.
    Liu X; Jia R; Zhao J; Li Z
    J Rheumatol; 2009 Jun; 36(6):1136-42. PubMed ID: 19447936
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Circulating immune complexes in rheumatoid arthritis. Selective removal by cryogelation with membrane filtration.
    Krakauer RS; Asanuma Y; Zawicki I; Calabrese L; Malchesky P; Nose Y
    Arch Intern Med; 1982 Feb; 142(2):395-7. PubMed ID: 6977346
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Efficacy of combined therapy with plasmapheresis and immunosuppressants in rheumatoid vasculitis.
    Winkelstein A; Starz TW; Agarwal A
    J Rheumatol; 1984 Apr; 11(2):162-6. PubMed ID: 6726715
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Bishofit in the treatment of rheumatoid arthritis].
    Zborovskiĭ AB; Martem'ianov VF; Sidorova EA; Mozgovaia EE; Zborovskaia IA
    Ter Arkh; 2003; 75(5):29-32. PubMed ID: 12847894
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Extracorporeal therapy of rheumatoid arthritis].
    Aseeva EA; Solov'ev SK; Chiklikchi AS
    Ter Arkh; 2001; 73(6):70-5. PubMed ID: 11521529
    [No Abstract]   [Full Text] [Related]  

  • 57. Mononuclear cell (MC) functions by cryofiltration (CF) in rheumatoid arthritis (RA).
    Naganuma S; Suzuki T; Dustoor MM; Goldcamp JB; Amano K; Yamashita M; Omokawa S; Koo AP; Malchesky PS; Clough JD
    Prog Clin Biol Res; 1990; 337():495-8. PubMed ID: 2191339
    [No Abstract]   [Full Text] [Related]  

  • 58. Is the disease course of rheumatoid arthritis becoming milder? Time trends since 1985 in an inception cohort of early rheumatoid arthritis.
    Welsing PM; Fransen J; van Riel PL
    Arthritis Rheum; 2005 Sep; 52(9):2616-24. PubMed ID: 16142762
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Anti-tumor necrosis factor-alpha response in rheumatoid arthritis is associated with an increase in serum soluble CD30.
    Gerli R; Lunardi C; Bocci EB; Bobbio-Pallavicini F; Schillaci G; Caporali R; Bistoni O; Pirro M; Pitzalis C; Montecucco C
    J Rheumatol; 2008 Jan; 35(1):14-9. PubMed ID: 18061981
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The Prosorba column for treatment of refractory rheumatoid arthritis: a randomized, double-blind, sham-controlled trial.
    Felson DT; LaValley MP; Baldassare AR; Block JA; Caldwell JR; Cannon GW; Deal C; Evans S; Fleischmann R; Gendreau RM; Harris ER; Matteson EL; Roth SH; Schumacher HR; Weisman MH; Furst DE
    Arthritis Rheum; 1999 Oct; 42(10):2153-9. PubMed ID: 10524687
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.